1. Market Research
  2. > Pharmaceutical Market Trends
  3. > New Zealand Pharmaceuticals and Healthcare Report Q3 2016

New Zealand Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 74 pages

Includes 3 FREE quarterly updates

BMI View: Innovative pharmaceutical firms will see limited upsides from New Zealand's newly adoptedhealth strategy for the next decade. Cost rationalisation remains a cornerstone of the government'sapproach and affirms the pharmaceutical management agency's stringent control on pharmaceuticalspending. Drugmakers will also have to adapt to shifts in patient flow as New Zealand seeks to encouragethe delivery of medical services within local communities.

Headline Expenditure Forecasts

- Pharmaceuticals: NZD1.48bn (USD1.0bn) in 2015 to NZD1.51bn (USD982mn) in 2016; 2.0% in localcurrency terms and -4.9% in US dollar terms.

- Healthcare: NZD27.42bn (USD19.13bn) in 2015 to NZD28.41bn (USD18.47bn) in 2016; 3.6% in localcurrency terms and -3.5% in US dollar terms.

Table Of Contents

New Zealand Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (New Zealand 2014-2020) 7
SWOT 9
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (New Zealand 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (New Zealand 2012-2020) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (New Zealand 2012-2020) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (New Zealand 2012-2020) 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (New Zealand 2012-2020) 21
OTC Medicine Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (New Zealand 2012-2020) 23
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (New Zealand 2014-2020) 25
Table: Pharmaceutical Trade Data And Forecasts local currency (New Zealand 2014-2020) 25
Industry Risk Reward Index 26
Asia Pacific Risk/Reward Index - Q3 2016 26
New Zealand Risk/Reward Index 32
Rewards 32
Risks 32
Regulatory Review 34
Regulatory Development 34
Intellectual Property Issues 34
Pricing and Reimbursement Regime 35
Table: Funding decisions for July - September 2014 40
Market Overview 42
Healthcare Sector 43
Table: Healthcare Resources (New Zealand 2010-2015) 44
Table: Healthcare Activity (New Zealand 2010-2015) 45
Table: Healthcare Personnel (New Zealand 2010-2015) 45
Research and Development 46
Clinical Trials 46
Epidemiology 48
Competitive Landscape 52
Research-Based Industry 52
Table: Multinational Market Activity 53
Pharmaceutical Distribution 53
Pharmaceutical Retail Sector 54
Company Profile 56
Douglas Pharmaceuticals 56
New Zealand Pharmaceuticals 59
Pfizer New Zealand 61
Demographic Forecast 63
Table: Population Headline Indicators (New Zealand 1990-2025) 64
Table: Key Population Ratios (New Zealand 1990-2025) 64
Table: Urban/Rural Population and Life Expectancy (New Zealand 1990-2025) 65
Table: Population By Age Group (New Zealand 1990-2025) 65
Table: Population By Age Group % (New Zealand 1990-2025) 66
Glossary 68
Methodology 70
Pharmaceutical Expenditure Forecast Model 70
Healthcare Expenditure Forecast Model 70
Notes On Methodology 71
Risk/Reward Index Methodology 72
Index Overview 73
Table: Pharmaceutical Risk/Reward Index Indicators 73
Indicator Weightings 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.